| 51 |
32947166 | Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells. | 2020 Nov |
1 |
| 52 |
32973533 | Hesperetin Promotes Cisplatin-Induced Apoptosis of Gastric Cancer In Vitro and In Vivo by Upregulating PTEN Expression. | 2020 |
2 |
| 53 |
33396645 | BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance. | 2020 Dec 30 |
1 |
| 54 |
33402832 | The effect of allicin on cell proliferation and apoptosis compared to blank control and cis-platinum in oral tongue squamous cell carcinoma. | 2020 |
1 |
| 55 |
30210134 | Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. | 2019 Feb 15 |
1 |
| 56 |
30257981 | Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers. | 2019 Jan 1 |
1 |
| 57 |
30503360 | Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA. | 2019 Feb 5 |
1 |
| 58 |
30614795 | The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer. | 2019 |
7 |
| 59 |
30747218 | Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway. | 2019 Mar |
1 |
| 60 |
30774376 | Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2. | 2019 |
6 |
| 61 |
30806186 | Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy? | 2019 Feb |
2 |
| 62 |
30867764 | Efficacy of celastrol combined with cisplatin in enhancing the apoptosis of U-2OS osteosarcoma cells via the mitochondrial and endoplasmic reticulum pathways of apoptosis. | 2019 Mar |
1 |
| 63 |
30875757 | Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. | 2019 Mar 14 |
1 |
| 64 |
30923410 | The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells. | 2019 Feb 28 |
1 |
| 65 |
31010222 | C-phycocyanin from Limnothrix Species KNUA002 Alleviates Cisplatin-Induced Ototoxicity by Blocking the Mitochondrial Apoptotic Pathway in Auditory Cells. | 2019 Apr 19 |
1 |
| 66 |
31076571 | Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling. | 2019 May 10 |
2 |
| 67 |
31079851 | Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2. | 2019 Jul |
1 |
| 68 |
31173289 | LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis. | 2019 May |
1 |
| 69 |
31239661 | Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. | 2019 |
1 |
| 70 |
31247208 | ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation. | 2019 Sep 1 |
1 |
| 71 |
31276572 | Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment. | 2019 |
1 |
| 72 |
31411791 | Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance. | 2019 Nov |
2 |
| 73 |
31432162 | Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth. | 2019 Oct |
1 |
| 74 |
31462500 | Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer. | 2019 Nov |
1 |
| 75 |
31518663 | Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer. | 2019 Nov |
5 |
| 76 |
31538075 | Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines. | 2019 Sep |
2 |
| 77 |
31541355 | A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p. | 2019 Dec |
1 |
| 78 |
31609766 | Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway. | 2019 Nov |
1 |
| 79 |
31611969 | MicroRNA-152 suppresses cisplatin resistance in A549 cells. | 2019 Nov |
1 |
| 80 |
31627336 | The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study. | 2019 Oct 17 |
2 |
| 81 |
31807162 | The inhibitory effects of cisplatin-radiation combination treatment on malignant osteosarcoma MG-63 cells and BRCA1-p53 pathways are more efficient than single treatments. | 2019 Dec |
1 |
| 82 |
31815138 | Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2/HO-1 and Bcl-2. | 2019 |
4 |
| 83 |
32010177 | Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells. | 2019 |
1 |
| 84 |
29091869 | Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways. | 2018 Jan |
1 |
| 85 |
29136958 | MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target. | 2018 Jan |
1 |
| 86 |
29196192 | Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin. | 2018 Mar |
1 |
| 87 |
29203930 | Downregulation of liver-intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells. | 2018 Feb |
1 |
| 88 |
29207009 | TAT‑fused IP3R‑derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release. | 2018 Feb |
5 |
| 89 |
29286126 | Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells. | 2018 Mar |
8 |
| 90 |
29322787 | Beclin1 enhances cisplatin-induced apoptosis via Bcl-2-modulated autophagy in laryngeal carcinoma cells Hep-2. | 2018 |
4 |
| 91 |
29352235 | Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells. | 2018 Jan 19 |
1 |
| 92 |
29352505 | p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells. | 2018 Jun |
3 |
| 93 |
29534504 | Inhibition of Intracellular ROS Accumulation by Formononetin Attenuates Cisplatin-Mediated Apoptosis in LLC-PK1 Cells. | 2018 Mar 12 |
1 |
| 94 |
29548748 | Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway. | 2018 May 15 |
1 |
| 95 |
29568392 | MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2. | 2018 Mar 2 |
4 |
| 96 |
29654165 | Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma. | 2018 Jun 29 |
1 |
| 97 |
29679655 | N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity. | 2018 Jun 15 |
1 |
| 98 |
29760419 | PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer. | 2018 May 14 |
3 |
| 99 |
29928364 | 53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells. | 2018 Jun |
2 |
| 100 |
29952351 | Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. | 2018 Jul 17 |
2 |